(Q40225359)

18 September 2017

Distribution of histone deacetylases 1-11 in the rat brain (English)

1 reference

18 September 2017

Ron S Broide

1

1 reference

18 September 2017

Jeff M Redwine

2

1 reference

18 September 2017

Najla Aftahi

3

1 reference

18 September 2017

Warren Young

4

1 reference

18 September 2017

Floyd E Bloom

5

1 reference

18 September 2017

Christopher J Winrow

6

1 reference

18 September 2017

1 January 2007

1 reference

Journal of Molecular Neuroscience

18 September 2017

1 reference

18 September 2017

31

1 reference

18 September 2017

47-58

1 reference

18 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02686117

18 September 2017

0 references

cites work

Expression profile of histone deacetylase 1 in gastric cancer tissues.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02686117

Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02686117

The choroid plexus in the rise, fall and repair of the brain

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.

1 reference

12 December 2020

Expression and activity of histone deacetylases in human asthmatic airways

1 reference

12 December 2020

Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family

1 reference

12 December 2020

Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain

1 reference

12 December 2020

Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases

1 reference

12 December 2020

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

1 reference

12 December 2020

Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers.

1 reference

12 December 2020

Histone deacetylase inhibitors and anticancer therapy

1 reference

12 December 2020

Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

1 reference

12 December 2020

Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity.

1 reference

12 December 2020

Trichostatin A attenuates airway inflammation in mouse asthma model

1 reference

12 December 2020

Prospects: histone deacetylase inhibitors

1 reference

12 December 2020

HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis.

1 reference

12 December 2020

Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation

1 reference

12 December 2020

Rational development of histone deacetylase inhibitors as anticancer agents: a review

1 reference

12 December 2020

HDAC-3 participates in the repression of e2f-dependent gene transcription in primary differentiated neurons

1 reference

12 December 2020

Histone deacetylase activity and COPD.

1 reference

12 December 2020

Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

1 reference

12 December 2020

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

1 reference

12 December 2020

Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228

1 reference

12 December 2020

The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress

1 reference

12 December 2020

Histone deacetylase inhibitors

1 reference

12 December 2020

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

1 reference

12 December 2020

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.

1 reference

12 December 2020

Histone acetyltransferases

1 reference

12 December 2020

Histone deacetylase inhibitors: latest developments, trends and prospects

1 reference

12 December 2020

Chromosomal organization and localization of the novel class IV human histone deacetylase 11 gene

1 reference

12 December 2020

Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein

1 reference

12 December 2020

Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction

1 reference

12 December 2020

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

1 reference

12 December 2020

Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration

1 reference

12 December 2020

Histone deacetylase 1 regulates retinal neurogenesis in zebrafish by suppressing Wnt and Notch signaling pathways.

1 reference

12 December 2020

Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation

1 reference

12 December 2020

Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene.

1 reference

12 December 2020

Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice

1 reference

12 December 2020

Upregulation of class II histone deacetylases mRNA during neural differentiation of cultured rat hippocampal progenitor cells

1 reference

12 December 2020

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Focus on deacetylation for therapeutic benefit

1 reference

12 December 2020

Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death.

1 reference

12 December 2020

Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents.

1 reference

12 December 2020

Acetylation inactivates the transcriptional repressor BCL6.

1 reference

12 December 2020

Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition

1 reference

12 December 2020

Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis.

1 reference

12 December 2020

Standardized quantitative in situ hybridization using radioactive oligonucleotide probes for detecting relative levels of mRNA transcripts verified by real-time PCR.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02686117

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference